Tivic Health Systems Files 8-K
Ticker: TIVC · Form: 8-K · Filed: Sep 18, 2024 · CIK: 1787740
Sentiment: neutral
Topics: reporting, sec-filing
Related Tickers: TIVC
TL;DR
Tivic Health filed a routine 8-K on 9/18/24, no major news.
AI Summary
Tivic Health Systems, Inc. filed an 8-K on September 18, 2024, to report other events and financial statements. The filing does not contain specific details about material events or financial figures within the provided text, but indicates a standard reporting procedure.
Why It Matters
This filing indicates Tivic Health Systems is adhering to its reporting obligations with the SEC, which is standard practice for publicly traded companies.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report and does not disclose any new material risks or adverse information.
Key Players & Entities
- Tivic Health Systems, Inc. (company) — Registrant
- September 18, 2024 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 001-41052 (commission_file_number) — SEC File Number
- 81-4016391 (irs_number) — IRS Employer Identification No.
- 47685 Lakeview Blvd. (address) — Principal Executive Offices
- Fremont (city) — Principal Executive Offices
- California (state) — Principal Executive Offices
- 94538 (zip_code) — Principal Executive Offices
- 888 276-6888 (phone_number) — Registrant's Telephone Number
FAQ
What is the primary purpose of this 8-K filing for Tivic Health Systems, Inc.?
The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of September 18, 2024.
On what date was this 8-K report filed?
This 8-K report was filed on September 18, 2024.
In which U.S. state is Tivic Health Systems, Inc. incorporated?
Tivic Health Systems, Inc. is incorporated in Delaware.
What is the principal executive office address for Tivic Health Systems, Inc.?
The principal executive office address is 47685 Lakeview Blvd., Fremont, California, 94538.
Does this filing disclose any specific material events or financial results?
Based on the provided text, this filing is a standard 8-K report and does not detail specific material events or financial results.
Filing Stats: 642 words · 3 min read · ~2 pages · Grade level 12.5 · Accepted 2024-09-18 09:00:14
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share TIVC The Nasdaq Stock Mar
Filing Documents
- tivc-20240918.htm (8-K) — 42KB
- tivc-ex99_1.htm (EX-99.1) — 24KB
- img553027_0.jpg (GRAPHIC) — 5KB
- 0000950170-24-107614.txt ( ) — 190KB
- tivc-20240918.xsd (EX-101.SCH) — 24KB
- tivc-20240918_htm.xml (XML) — 5KB
01 Other Events
Item 8.01 Other Events. On September 18, 2024, Tivic Health Systems, Inc. (the "Company") issued a press release announcing it has received approval from The Feinstein Institutes' Institutional Review Board for the next phase of clinical work on its non-invasive cervical vagus nerve stimulation approach. The full text of that press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K (this "Current Report"), and is incorporated herein by reference.
Forward-Looking Statements
Forward-Looking Statements This Current Report, including Exhibit 99.1 attached hereto, contains certain forward-looking statements that involve substantial risks and uncertainties. When used herein, the terms "anticipates," "expects," "estimates," "believes," "will" and similar expressions, as they relate to us or our management, are intended to identify such forward-looking statements. Forward-looking statements in this Current Report, including Exhibit 99.1 attached hereto, or hereafter, including in other publicly available documents filed with the Securities and Exchange Commission, reports to the stockholders of the Company and other publicly available statements issued or released by us involve known and unknown risks, uncertainties and other factors which could cause our actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. Such future results are based upon management's best estimates based upon current conditions and the most recent results of operations. These risks include, but are not limited to, the risks set forth herein and in such other documents filed with the Securities and Exchange Commission, each of which could adversely affect our business and the accuracy of the forward-looking statements contained herein.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Description 99.1 Press Release, September 18, 2024 . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. TIVIC HEALTH SYSTEMS, INC. Date: September 18, 2024 By: /s/ Jennifer Ernst Name: Jennifer Ernst Title: Chief Executive Officer